ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive: These findings suggest that the chemotherapeutic sensitivity and the fractions of ABCG2 and SP cells in drug-resistant CML might be mediated by the PI3K/Akt signaling pathway, which is consistent with our previous reports in acute leukemia [41].